NovoTTF-200T for Non-Small Cell Lung Cancer

"Sarcoma, malignant neoplasms, and patients with advance directives can all be treated with either Immune checkpoint inhibitors or docetaxel."

"With St. Joseph Heritage Healthcare in Fullerton, California, Banner MD Anderson Cancer Center at North Colorado Medical Center in Greeley, Colorado, and Saddleback Memorial Medical Center in Laguna Hills, Texas as the primary locations, this study is also running in 65 other places."

"The clinicaltrials.gov website says that this study isn't looking for new participants at the moment. The trial was originally posted on December 1st, 2016 but the most recent update was on October 13th, 2022. There are 2414 other trials that are currently looking for participants."

"As of now, this study is no longer recruiting patients. Although, when it was active, the trial was posted on December 1st, 2016 and last edited on October 13th, 2022. For those still seeking studies, 2079 trials for lung cancer and 335 for Immune checkpoint inhibitors or docetaxel are still looking for patients."

"There are currently 335 active clinical trials investigating the use of immune checkpoint inhibitors or docetaxel, with 132 of those trials in Phase 3. The majority of these trials are located in Fuzhou, Fujian, but there are 22962 locations around the world conducting these trials."

"Immune checkpoint inhibitors or docetaxel have a safety rating of 3, as they have undergone multiple rounds of clinical trials with positive results."